Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-05-01-2001
Volume0
Issue 0

The Next Y2K

Author(s):

Mark E. Kolb

Companies Face Costly System Overhauls With New FDA Regulations

Articles in this issue
Policy: Task Masters
Pharmacia's Carrie Cox: HBA Woman of the Year
Friends of Complexity
Under Federal Fire
Task Force: Enter the Fixers
The Next Y2K

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Pharmaceutical Executive
Pharmaceutical Executive
Helen Sabzevari
Related Content
Lawrence M. Blatt
September 15th 2025

Lawrence M. Blatt on Taking the Leap from Scientist to Founder

PE Staff
Stock.adobe.com
September 15th 2025

Pharmaceutical Executive Daily: September 15, 2025

Nicholas Jacobus
Stock.adobe.com
September 15th 2025

Novartis and Monte Rosa Therapeutics Announce $5.7 Billion Licensing Agreement Deal for Protein Degraders

Nicholas Jacobus
Pharmaceutical Executive
September 15th 2025

Pharmaceutical Executive Daily: September 12, 2025

Nicholas Jacobus
Stock.adobe.com
September 15th 2025

Everything to Know About the COVID 19 Vaccines in 2025

Mike Hollan
Site Logo
September 15th 2025

9 Ways To Use Microlearning To Train Life Sciences Commercial Teams

QStream
© 2025 MJH Life Sciences

All rights reserved.